Insider Transactions
| Date | Name | Title | Type | Filing | Shares Traded | Price Range | Total Held |
|---|---|---|---|---|---|---|---|
| Jan 16, 2019 | Chief Science Officer | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Form 4 | 4,988 | -- | -- | |
| Jan 15, 2019 | Director, Chairman & CEO | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Form 4 | 103,500 | -- | -- | |
| Sep 11, 2018 | Director | Initial Statement of Beneficial Ownership of Securities | Form 3 | -- | -- | -- | |
| Jun 15, 2018 | Principal Accounting Officer | Initial Statement of Beneficial Ownership of Securities | Form 3 | -- | -- | -- | |
| Apr 16, 2018 | Director | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Form 4 | 5,000 | -- | -- | |
| Mar 09, 2018 | SVP, Finance | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Form 4 | 8,750 | -- | -- | |
| Mar 01, 2018 | SVP, Finance | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Form 4 | 8,149 | -- | -- | |
| Jan 22, 2018 | Chief Operating Officer | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Form 4 | 32,500 | -- | -- | |
| Jan 02, 2018 | Director | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Form 4 | 10,000 | -- | -- | |
| Jan 02, 2018 | Director | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Form 4 | 10,000 | -- | -- |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.